Publicaciones en colaboración con investigadores/as de Jewish General Hospital (26)

2023

  1. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

    Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883

2022

  1. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180

    Computer methods and programs in biomedicine

2021

  1. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression

    Computer Methods and Programs in Biomedicine, Vol. 208

2018

  1. Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort

    Clinical and Experimental Rheumatology, Vol. 36, pp. S53-S60

  2. Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol

    Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 91-97

  3. The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts

    Rheumatology (United Kingdom), Vol. 57, Núm. 9, pp. 1623-1631

  4. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study

    Arthritis Care and Research, Vol. 70, Núm. 10, pp. 1557-1562

  5. Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study

    Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 98-105

2017

  1. Contribution of different relapse phenotypes to disability in multiple sclerosis

    Multiple Sclerosis, Vol. 23, Núm. 2, pp. 266-276

  2. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 5, pp. 1067-1077

  3. Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

    Multiple Sclerosis, Vol. 23, Núm. 10, pp. 1346-1357

  4. Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response

    Brain, Vol. 140, Núm. 9, pp. 2426-2443

2016

  1. Defining secondary progressive multiple sclerosis

    Brain, Vol. 139, Núm. 9, pp. 2395-2405

  2. Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

    Clinical and Experimental Rheumatology, Vol. 34, pp. 92-99

  3. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

    Multiple Sclerosis, Vol. 22, Núm. 4, pp. 520-532

  4. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study

    Arthritis Care and Research, Vol. 68, Núm. 8, pp. 1195-1200

2015

  1. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

    Multiple Sclerosis, Vol. 21, Núm. 9, pp. 1159-1171

  2. Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 1

  3. Predictors of disability worsening in clinically isolated syndrome

    Annals of Clinical and Translational Neurology, Vol. 2, Núm. 5, pp. 479-491

2014

  1. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey

    Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 5, pp. 666-672